WO2005048693A2 - Plante a tolerance accrue a la secheresse - Google Patents
Plante a tolerance accrue a la secheresse Download PDFInfo
- Publication number
- WO2005048693A2 WO2005048693A2 PCT/IB2004/052440 IB2004052440W WO2005048693A2 WO 2005048693 A2 WO2005048693 A2 WO 2005048693A2 IB 2004052440 W IB2004052440 W IB 2004052440W WO 2005048693 A2 WO2005048693 A2 WO 2005048693A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- gene
- cbp20
- homologue
- drought tolerance
- Prior art date
Links
- 230000001976 improved effect Effects 0.000 title claims abstract description 30
- 230000024346 drought recovery Effects 0.000 title claims abstract description 28
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 91
- 238000000034 method Methods 0.000 claims abstract description 48
- 108091000106 RNA cap binding Proteins 0.000 claims abstract description 33
- 102000028391 RNA cap binding Human genes 0.000 claims abstract description 32
- 230000009261 transgenic effect Effects 0.000 claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 claims abstract description 10
- 230000003247 decreasing effect Effects 0.000 claims abstract description 9
- 238000010353 genetic engineering Methods 0.000 claims abstract description 4
- 241000196324 Embryophyta Species 0.000 claims description 164
- 230000014509 gene expression Effects 0.000 claims description 31
- 230000001105 regulatory effect Effects 0.000 claims description 30
- 101150105864 CBP20 gene Proteins 0.000 claims description 29
- 150000007523 nucleic acids Chemical class 0.000 claims description 25
- 241000219194 Arabidopsis Species 0.000 claims description 19
- 230000035772 mutation Effects 0.000 claims description 16
- 102000039446 nucleic acids Human genes 0.000 claims description 16
- 108020004707 nucleic acids Proteins 0.000 claims description 16
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 15
- 108091026890 Coding region Proteins 0.000 claims description 14
- 238000002703 mutagenesis Methods 0.000 claims description 12
- 231100000350 mutagenesis Toxicity 0.000 claims description 12
- 125000003729 nucleotide group Chemical group 0.000 claims description 9
- 230000004983 pleiotropic effect Effects 0.000 claims description 9
- 230000000903 blocking effect Effects 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 8
- 238000013518 transcription Methods 0.000 claims description 8
- 230000035897 transcription Effects 0.000 claims description 8
- 230000000692 anti-sense effect Effects 0.000 claims description 7
- 230000001568 sexual effect Effects 0.000 claims description 6
- 238000012225 targeting induced local lesions in genomes Methods 0.000 claims description 6
- 210000000056 organ Anatomy 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000009396 hybridization Methods 0.000 claims description 3
- 230000002401 inhibitory effect Effects 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 241000219193 Brassicaceae Species 0.000 claims description 2
- 241000218980 Brassicales Species 0.000 claims description 2
- 238000012217 deletion Methods 0.000 claims description 2
- 230000037430 deletion Effects 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 238000012163 sequencing technique Methods 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 101000829171 Hypocrea virens (strain Gv29-8 / FGSC 10586) Effector TSP1 Proteins 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 34
- 230000006870 function Effects 0.000 description 28
- 108020004414 DNA Proteins 0.000 description 22
- 102000004169 proteins and genes Human genes 0.000 description 20
- 101150076426 Ncbp2 gene Proteins 0.000 description 15
- 108020004999 messenger RNA Proteins 0.000 description 14
- 230000030279 gene silencing Effects 0.000 description 12
- 230000035882 stress Effects 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 108700019146 Transgenes Proteins 0.000 description 9
- 241000894007 species Species 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 238000012216 screening Methods 0.000 description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- JLIDBLDQVAYHNE-YKALOCIXSA-N abscisic acid group Chemical group C\C(\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C)=C\C(O)=O JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000002708 random mutagenesis Methods 0.000 description 7
- 230000009466 transformation Effects 0.000 description 7
- 102000001745 Nuclear Cap-Binding Protein Complex Human genes 0.000 description 6
- 125000003275 alpha amino acid group Chemical group 0.000 description 6
- 108091033319 polynucleotide Proteins 0.000 description 6
- 102000040430 polynucleotide Human genes 0.000 description 6
- 239000002157 polynucleotide Substances 0.000 description 6
- 230000014616 translation Effects 0.000 description 6
- 108010029782 Nuclear Cap-Binding Protein Complex Proteins 0.000 description 5
- 240000007594 Oryza sativa Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000003623 enhancer Substances 0.000 description 5
- 238000002493 microarray Methods 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000219195 Arabidopsis thaliana Species 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000012226 gene silencing method Methods 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 239000003471 mutagenic agent Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000019491 signal transduction Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 101100025889 Arabidopsis thaliana CBP20 gene Proteins 0.000 description 3
- 108091092195 Intron Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 102100035712 Serrate RNA effector molecule homolog Human genes 0.000 description 3
- 108010036039 Serrate-Jagged Proteins Proteins 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 238000012252 genetic analysis Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000002743 insertional mutagenesis Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 101150114738 ABH1 gene Proteins 0.000 description 2
- 101100232310 Agaricus bisporus hypA gene Proteins 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 2
- 108020005544 Antisense RNA Proteins 0.000 description 2
- 208000005156 Dehydration Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- 108700024394 Exon Proteins 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 101100269633 Homo sapiens ALKBH1 gene Proteins 0.000 description 2
- 102100027051 Nucleic acid dioxygenase ALKBH1 Human genes 0.000 description 2
- 230000004570 RNA-binding Effects 0.000 description 2
- 108020005038 Terminator Codon Proteins 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 239000003184 complementary RNA Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 244000038559 crop plants Species 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- -1 electroporation Substances 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 230000006353 environmental stress Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 238000012261 overproduction Methods 0.000 description 2
- 230000037039 plant physiology Effects 0.000 description 2
- 230000001124 posttranscriptional effect Effects 0.000 description 2
- 230000009822 protein phosphorylation Effects 0.000 description 2
- 230000009291 secondary effect Effects 0.000 description 2
- 238000010187 selection method Methods 0.000 description 2
- 230000011869 shoot development Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000005026 transcription initiation Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- ZBMRKNMTMPPMMK-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid;azane Chemical compound [NH4+].CP(O)(=O)CCC(N)C([O-])=O ZBMRKNMTMPPMMK-UHFFFAOYSA-N 0.000 description 1
- JLIDBLDQVAYHNE-LXGGSRJLSA-N 2-cis-abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\C1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-LXGGSRJLSA-N 0.000 description 1
- XUDNWQSXPROHLK-OACYRQNASA-N 2-phenyl-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC=CC=2)OC2=CC=CC=C2C1=O XUDNWQSXPROHLK-OACYRQNASA-N 0.000 description 1
- 101150017339 ABI5 gene Proteins 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 108700024227 Arabidopsis SE Proteins 0.000 description 1
- 101100483373 Arabidopsis thaliana UGT73C6 gene Proteins 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108010049994 Chloroplast Proteins Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 230000007067 DNA methylation Effects 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108091027757 Deoxyribozyme Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000012858 Eukaryotic Initiation Factor-4G Human genes 0.000 description 1
- 108010057192 Eukaryotic Initiation Factor-4G Proteins 0.000 description 1
- 101710091918 Eukaryotic translation initiation factor 4E Proteins 0.000 description 1
- 102100027304 Eukaryotic translation initiation factor 4E Human genes 0.000 description 1
- 101710126428 Eukaryotic translation initiation factor 4E-2 Proteins 0.000 description 1
- 101710126416 Eukaryotic translation initiation factor 4E-3 Proteins 0.000 description 1
- 101710126432 Eukaryotic translation initiation factor 4E1 Proteins 0.000 description 1
- 101710091919 Eukaryotic translation initiation factor 4G Proteins 0.000 description 1
- 101710133325 Eukaryotic translation initiation factor NCBP Proteins 0.000 description 1
- 101710190212 Eukaryotic translation initiation factor isoform 4E Proteins 0.000 description 1
- 101710124729 Eukaryotic translation initiation factor isoform 4E-2 Proteins 0.000 description 1
- 102000009465 Growth Factor Receptors Human genes 0.000 description 1
- 108010009202 Growth Factor Receptors Proteins 0.000 description 1
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 108091027305 Heteroduplex Proteins 0.000 description 1
- 102100021467 Histone acetyltransferase type B catalytic subunit Human genes 0.000 description 1
- 101000898976 Homo sapiens Histone acetyltransferase type B catalytic subunit Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- HDAJUGGARUFROU-JSUDGWJLSA-L MoO2-molybdopterin cofactor Chemical compound O([C@H]1NC=2N=C(NC(=O)C=2N[C@H]11)N)[C@H](COP(O)(O)=O)C2=C1S[Mo](=O)(=O)S2 HDAJUGGARUFROU-JSUDGWJLSA-L 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 102000015097 RNA Splicing Factors Human genes 0.000 description 1
- 108010039259 RNA Splicing Factors Proteins 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 102000039471 Small Nuclear RNA Human genes 0.000 description 1
- 108020004688 Small Nuclear RNA Proteins 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 241000251131 Sphyrna Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 108700026226 TATA Box Proteins 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 101710185494 Zinc finger protein Proteins 0.000 description 1
- 102100023597 Zinc finger protein 816 Human genes 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000036579 abiotic stress Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000008649 adaptation response Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000010310 bacterial transformation Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000004790 biotic stress Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 102000021178 chitin binding proteins Human genes 0.000 description 1
- 108091011157 chitin binding proteins Proteins 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000003721 exogen phase Effects 0.000 description 1
- 230000004077 genetic alteration Effects 0.000 description 1
- 231100000118 genetic alteration Toxicity 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000011544 gradient gel Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 108010046778 molybdenum cofactor Proteins 0.000 description 1
- 230000008722 morphological abnormality Effects 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 101150021549 ncbp1 gene Proteins 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 230000036178 pleiotropy Effects 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000008399 response to wounding Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 102000023888 sequence-specific DNA binding proteins Human genes 0.000 description 1
- 108091008420 sequence-specific DNA binding proteins Proteins 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8273—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for drought, cold, salt resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Definitions
- the present invention relates to a plant with improved drought tolerance that is transgenic and/or mutagenized chemically and/or physically, wherein the function of the Cap Binding Protein (CBP20) gene or a homologue thereof is decreased or blocked due to genetic manipulation and/or mutagenization.
- the invention further relates to constructs used for the manipulation and/or mutagenezis, as well as methods for the production of the plant with improved drought tolerance.
- Agronomicallyimportant genes can be isolated in several different ways.
- a generally used strategy is direct mapping of genes responsible for favorable traits in crop species, followed by map based cloning. This approach is, however, hampered by the relatively scarce information available in these species.
- Activation or inactivation of an important signaling pathway in a plant may cause multiple phenotypic changes beside the primary biochemical or physiological defect (pleiotropy). These changes may affect the plant's stature, growth, developmental phases or other parameters that can be scored relatively easily. Based on these subtle changes, mutants often can be spotted easily in a mutant plant population. In a functional genomic screen these mutants may be tested further to reveal the primary nature of the mutation, with special emphasis on the scientifically or agronomically useful traits they may carry. Practically, this means a second round of rigorous screening, where the selected mutants are tested under a number of different stress conditions.
- a method that has been employed to this end is conventional breeding, where crossings and selection is used to improve the characteristics of the particular variety (see e.g. Hungarian Patent No. 218 309 and US Patent No. P9885).
- transgenic techniques are used more and more often to tailor the physiology of a plant to resist environmental stresses, such as drought.
- a few examples for this method overproduction of a molybdenum-cofactor sulphurase, which yields the cofactor of the last enzyme of abscisic acid (ABA) biosynthesis (US patent application No. 2003/0084485); increasing the raff ⁇ nose content of a plant by transgenic means (US patent application No. 2003/0074696A1); overproduction of the ABI5 protein - which is a stress-induced transcription factor - (US patent application No. 2002/0174454A1).
- ABA abscisic acid
- nCBC nuclear cap binding complex
- the core of the nCBC complex consists of the Cap Binding Proteins CBP80, CBP20 (with molecular weights of 80 and 20 kDa, respectively) bound by an additional handful of proteins, including eIF4G [McKendrick, L., Thompson, E., Ferreira, J., Morley, S.J., Lewis, J.D., Interaction of eukaryotic translation initiation factor 4G with the nuclear cap-binding complex provides a link between nuclear and cytoplasmic functions of the m 7 guanosine cap., Mol. Cell. Biol. 21, pp. 3632-3641 (2001)].
- eIF4G McKendrick, L., Thompson, E., Ferreira, J., Morley, S.J., Lewis, J.D.
- CBP20 has also been used in the literature to designate the chitin binding protein, unrelated to the subject of the present invention; see Ponstein A.S. et al., Plant Physiology 104(1), pp. 109-118 (1994)].
- CBP80 and CBP20 are able to bind the 5' cap structure together.
- the full biological function of nCBC however is probably achieved in a complex interaction with all the proteins participating in the complex.
- CBP20 is the subunit that binds the 5' cap directly, and the details of this interaction are well documented [Calero G. et al., Nat. Struct. Biol. 9(12), pp. 912-917 (2002)].
- nCBC is implicated in mRNA splicing, 3' end maturation and in the export of U snRNA from the nucleus [Izaurralde, E., Lewis, J., McGuigan, C, Jankowska, M., Darzynkiewicz, E., Mattaj, I.W., A nuclear cap binding protein complex involved in pre-mRNA splicing., Cell 78, pp. 657-668 (1994); Flaherty, S., Fortes, P., Izaurralde, E., Mattaj, I.W., Gilmartin, G:M., Participation of the nuclear cap binding complex in pre-mRNA 3' processing., Proc. Natl. Acad. Sci. USA 94, pp. 11893-11898 (1997)].
- nCBC itself is known to be regulated posttranscriptionally by protein phosphorylation in mammals.
- the rice homolog for the CBP80 protein is detailed in WO02/081696. It is therefore likely that, at least structurally, nCBC is evolutionally conserved in dicotyledonous and monocotyledonous plants and animals (see references above), as well as in yeast [e.g. see Colot et al., The yeast splicing factor Mudl3p is a commitment complex component and corresponds to CBP20, the small subunit of the nuclear cap-binding complex., Genes Dev. 10, pp. 1699-1708 (1996)].
- Clark et al. have investigated the effects of different mutations on alternative splicing in yeast by splicing specific microarrays [Clark, T.A., Sugnet, C.W. and Ares, M., Genom wide analysis of mRNA processing in yeast using splicing-specif ⁇ c microarrays., Science 296, pp. 907-910 (2002)].
- the gcr3 and mudl3 yeast mutants (corresponding to cbp80 and cbp20, respectively) do not have the same effect on the accumulation of the spliced RNA set of the yeast. Consequently the two proteins may have at least partially different functions in the cell.
- the Arabidopsis mutant line with improved drought tolerance made by the present inventors carried a lesion in the CBP20 gene, which is likely a member of the nCBC complex.
- the nucleotide and amino acid sequence of CBP20 gene is presented on SEQ. ID. NOs. 1 and 2, respectively.
- the Arabidopsis mutant line with improved drought tolerance made by the present inventors carried a lesion in the CBP20 gene, which is likely a member of the nCBC complex.
- the nucleotide and amino acid sequence of CBP20 gene is presented on SEQ. ID. NOs. 1 and 2, respectively.
- the term 'gene' refers to a nucleic acid fragment that expresses mRNA, functional RNA, or specific protein, including its regulatory sequences.
- the term 'native gene' refers to gene as found in nature.
- a 'transgene' refers to a gene that has been introduced into the genome by transformation and is stably maintained. Transgenes may include, for example, genes that are either heterologous or homologous to the genes of a particular plant to be transformed. Additionally, transgenes may comprise native genes inserted into a non-native organism, or chimeric genes.
- the term 'endogenous gene' refers to a native gene in its natural location in the genome of an organism.
- the term 'coding sequence' refers to a DNA or RNA sequence that codes for a specific amino acid sequence and excludes the non-coding sequences.
- the terms 'open reading frame' and 'ORF' refer to the amino acid sequence encoded between translation initiation and termination codons of a coding sequence.
- the terms 'initiation codon' and 'termination codon' refer to units of three adjacent nucleotides ('codon') in a coding sequence that specifies initiation and chain termination, respectively, of protein synthesis (mRNA translation).
- the terms 'regulatory sequences' refers to nucleotide sequences located upstream (5' non-coding sequences), within, or downstream (3' non-coding sequences) of a coding sequence, and which influence the transcription, RNA processing or stability, or translation of the associated coding sequence. Regulatory sequences include enhancers, promoters, translation leader sequences, introns, and polyadenylation signal sequences. They include natural and synthetic sequences, as well as sequences which may be a combination of synthetic and natural sequences. Some regulatory sequences useful in the present invention will include, but are not limited to constitutive plant promoters, plant tissue-specific promoters, plant developmental stage-specific promoters, inducible plant promoters and viral promoters.
- the '3' region' means the 3' non-coding regulatory sequences located downstream of a coding sequence. This DNA can influence the transcription, RNA processing or stability, or translation of the associated coding sequence.
- the term 'promoter' refers to a nucleotide sequence, usually upstream (5') to its coding sequence, which controls the expression of the coding sequence by providing the recognition for RNA polymerase and other factors required for proper transcription.
- the term 'promoter' includes a minimal promoter that is a short DNA sequence comprised of a TATA-box and other sequences that serve to specify the site of transcription initiation, to which regulatory elements are added for control of expression.
- 'Promoter' also refers to a nucleotide sequence that includes a minimal promoter plus regulatory elements that is capable of controlling the expression of a coding sequence or functional RNA.
- promoter sequence consists of proximal and more distal upstream elements, the latter elements often referred to as enhancers.
- an 'enhancer' is a DNA sequence which can stimulate promoter activity and may be an innate element of the promoter or a heterologous element inserted to enhance the level or tissue specificity of a promoter. It is capable of operating in both orientations (normal or flipped), and is capable of functioning even when moved either upstream or downstream from the promoter.
- enhancers and other upstream promoter elements bind sequence-specific DNA-binding proteins that mediate their effects. Promoters may be derived in their entirety from a native gene, or be composed of different elements derived from different promoters found in nature, or even be comprised of synthetic DNA segments.
- a promoter may also contain DNA sequences that are involved in the binding of protein factors which control the effectiveness of transcription initiation in response to physiological or developmental conditions.
- the term 'homologue' or 'variant' of a nucleic acid sequence refers to a sequence having at least 50%, preferably at least 70%, more preferably at least 80%, even more preferably at least 90%, and still more preferably at least 95% sequence identity with the said sequence.
- the FastDB program of EMBL or SWISSPROT data bases can be used.
- Other algorithms and computerized embodiments thereof well known in the art may also be used for the determination of this homology.
- the term 'homologue' or 'variant' of an amino acid sequence is defined similarly to that of nucleic acid sequences. Therefore, the term 'homologue' or 'variant' of an amino acid sequence refers to a sequence having at least 70%, preferably at least 80%, more preferably at least 90%, even more preferably at least 95%, and still more preferably at least 98% sequence identity with the said sequence. To determine whether the sequences are homologous, the above-mentioned programs and algorithms may be used.
- 'Isolated' means altered 'by the hand of man' from natural state. If an 'isolated' composition or substance occurs in nature, it has been changed or removed from its original environment, or both.
- a polynucleotide or a polypeptide naturally present in a living animal is not 'isolated', but the same polynucleotide or polypeptide separated from the coexisting materials of its natural state is 'isolated', as the term employed herein.
- a nucleic acid molecule is regarded 'hybridizable' with another nucleic acid molecule if it can specifically be bound to the other molecule (i.e., the binding can give rise to a signal that is distinguishable from the background noise and from the signal caused by the non-specific binding of any random sequenced nucleic acid molecule), preferably a nucleic acid molecule is regarded as hybridizable if it specifically binds to another nucleic acid molecule under stringent conditions.
- a regulatory sequence is 'operably linked' to a structural gene within a DNA construct if the regulatory sequence is able to influence the expression rate or manner of said structural gene under conditions suitable for the expression of said structural gene and for the functioning of said regulatory sequence.
- the terms 'transformed', 'transformant' and 'transgenic' refer to plants or calli that have been through the transformation process and contain a foreign gene integrated into their chromosome.
- the term 'untransformed' refers to normal plants that have not been through the transformation process.
- 'transgenic plant' includes reference to a plant, which comprises within its genome a heterologous polynucleotide.
- the heterologous polynucleotide is stably integrated within the genome such that the polynucleotide is passed on to successive generations.
- the heterologous polynucleotide may be integrated into the genome alone or as part of a recombinant expression cassette.
- 'Transgenic' is used herein to include any cell, cell line, callus, tissue, plant part or plant, the genotype of which has been altered by the presence of heterologous nucleic acid including those transgenics initially so altered as well as those created by sexual crosses or asexual propagation from the initial transgenic.
- transgenic' does not encompass the alteration of the genome (chromosomal or extra- chromosomal) by conventional plant breeding methods or by naturally occurring events such as random cross-fertilization, non-recombinant viral infection, non- recombinant bacterial transformation, non-recombinant transposition, or spontaneous mutation.
- the function of a gene is 'decreased', 'inhibited' or 'blocked' if the expression or transcription of the gene, the splicing of the RNA transcribed from the gene, or the transport, membrane integration, activation or activity of the protein encoded by the gene, or any other molecular, cellular or plant level process having a role in the expression or function of the gene or the product encoded, is lowered, such as about 75%), preferably about 50%, more preferably about 25%, even more preferably about 10%, more preferably even about 5%, or most preferably completely blocked, that is about 0%, compared to the same function of the wild type plant.
- the present invention relates to a plant with improved drought tolerance that is transgenic and/or mutagenized chemically and/or physically, wherein the function of the Cap Binding Protein (CBP20) gene or a homologue thereof is decreased or blocked due to genetic manipulation and/or mutagenization.
- CBP20 Cap Binding Protein
- the present invention relates to a plant wherein the function of the CBP20 gene or a homologue thereof is decreased or blocked by addition, deletion and/or substitution of one or more nucleotide within the regulatory and/or coding region of the gene.
- the invention relates to a plant wherein the function of the CBP20 gene or a homologue thereof is decreased or blocked by introduction of a re- combinant construct that leaves the regulatory and/or coding region of the gene intact.
- the said plant is dicotyledonous, preferably the plant belongs to the order of Brassicales, and more preferably to the family of Brassicaceae. In a highly preferred embodiment, the plant is Arabidopsis.
- the plant is monocotyledonous.
- the invention also relates to a cell, tissue, organ, part, seed, fruit, product, progeny or propagation material of the plant according to the invention.
- the invention relates to a recombinant nucleic acid construct comprising a nucleic acid inhibiting or blocking the CBP20 gene upon its expression, operably linked to a regulatory sequence capable of directing transcription in a plant.
- the construct according to the invention comprises a nucleic acid sequence encoding the CBP20 gene or a homologue thereof in its entirety or a part thereof in antisense direction with respect to the regulatory sequence.
- the construct according to the invention comprises a nucleic acid sequence encoding the CBP20 gene or a homologue thereof in its entirety or a part thereof in sense direction with respect to the regulatory sequence.
- the construct according to the invention comprises a nucleic acid sequence encoding the CBP20 gene or a homologue thereof in its entirety or a part thereof in an inverted repeat arrangement.
- the invention further relates to a method for the production of a plant with improved drought tolerance comprising the preparation a mutagenized plant population by random mutagenezis; selection of the mutagenized plants by molecular biological techniques capable of recognizing mutations within the CBP20 gene or homologues thereof; and optional sexual or asexual propagation of the resulting plants with improved drought tolerance.
- the invention relates to a method for the production of a plant with improved drought tolerance comprising the preparation a mutagenized plant population by introducing a nucleic acid construct suitable for the mutagenesis or functional blocking of the CBP20 gene or homologue thereof; selection of the mutagenized plants with improved drought tolerance; and optional sexual or asexual propagation of the resulting plant with improved drought tolerance.
- the invention relates to a method wherein a construct according to the invention is used for the mutagenesis or functional blocking of the gene.
- the invention relates to a method wherein a wherein the mutation within the CBP20 gene or homologue thereof is preferably detected hybridization, sequencing, PCR, SSCP, and/or TILLING.
- the invention also relates to a method wherein during the selection step the plant population is screened in advance for visible pleiotropic features being characteristic of plants comprising a mutant CBP20 gene or a homologue thereof.
- Figure 1 shows wild type (on the left) and cbp20 mutant (on the right) plants and leaves.
- Figure 2 shows leaves of cbp20 and serrate (se) plants, and their FI progeny.
- Figure 3 shows the result of T-DNA specific PCR on F2 plants with wild type (panel A) and mutant (panel B) phenotype.
- Figure 4 shows Northern hybridization on total RNA samples prepared from wild type (on the left) and cbp20 mutant (on the right) plants.
- Figure 5 shows wild type and cbp20 mutant plants following 8 days of water deprivation.
- drought resistant plant according to the invention can be obtained by damaging (i.e. inhibiting or completely blocking) the CBP20 gene or gene expression. Damaging of the CBP20 gene or gene expression can be achieved by introducing DNA constructs into the plant.
- Ti derived plasmids transform a wide range of higher plants, including monocot and dicot plants such as soybean, cotton, rape, tobacco and rice [Pacciotti et al., Bio/Technology 3, p. 241 (1985); Byrne et al., Plant Cell, Tissue and Organ Culture 8, p. 3 (1987); Sukhapinda et al., Plant Mol. Biol. 8, pp. 209-216 (1987); Lorz et al., Mol. Gen. Genet. 199, p. 178 (1985); Potrykus et al., Mol. Gen. Genet. 199, p. 183 (1985); Park et al., J. Plant Biol. 38, pp.
- RNA construct is designed covering the full or partial sequence of the target gene (may include exons, introns, 5' or 3' untranslated regions of mRNA) in antisense orientation, operably linked to a promoter suitable in the plant manipulated.
- a minimum of 40-50 base pair homology is generally thought to be required to achieve silencing, in general practice a ⁇ 300-400 base pair long DNA sequence is used.
- antisense RNA is synthesized from this construct that may disturb the expression of the target gene at different levels.
- the nucleic acid delivered to the cell may be antisense DNA or RNA oligonucleotide as well.
- the antisense nucleic acid may hybridize with the target mRNA, yielding double stranded RNA that is degraded by the host cell, preventing the expression of the gene [Matzke and Matzke, Plant Physiology 107, pp. 679-685 (1995), Vaucheret et al., The Plant Journal 16, pp. 651-659 (1998), Mlotshwa et al., Plant Cell 14 Suppl, pp. 289-301 (2002)].
- the silencing construct need not be fully homologous with the target sequence, moreover one construct may silence more than one target genes.
- Sense suppression The target gene or a part of its sequence is overexpressed in the plant, driven by a promoter that is functional in the plant. In some cases this leads to silencing of the introduced and endogenous genes, or any homolog sequences in the genome. Presumably there is a control mechanism in the cell degrading the mRNA species in excess [Taylor C.B., Plant Cell 9, pp. 1245-1249 (1997), Jorgensen et al., Trends in Genetics 15, pp. 11-12 (1999), Fagard and Vaucheret, Annu. Rev. Plant Physiol. Plant Mol. Biol. 51, pp. 167-194 (2000)].
- the silencing construct may contain the promoter of the gene, exons, introns, 5' or 3' non-translatable regions or coding sequences of the target gene or parts of these elements [Brummell et al., Inverted repeat of a heterologous 3'-nontranslated region for high-efficiency, high-throughput gene silencing., Plant J. 33, pp. 793-800 (2003); Aufsatz et al., RNA-directed DNA methylation in Arabidopsis., Proc. Natl. Acad. Sci. USA 99 Suppl 4, pp. 16499-16506 (2002)].
- the size of the silencing construct required is similar to that of used in the antisense method, there is no need for full homology, and multiple genes can be targeted at once, as well.
- the regulatory (promoter) elements controlling the expression of the above constructs may work constitutively, but can also be regulated. Stress induced transgene expression is described in response to wounding by Rizhsky L. and Mittler R. [Plant Mol. Biol. 46, pp. 313-323 (2001)], pathogen attack [Strittmatter G. et al., Bio/ Technology 13, pp. 1085-1089 (1995)], drought or ABA induction [Su J. et al., Plant Physiol. 117, pp. 913-922 (1998)]. Regulated expression has the obvious advantage that any secondary effect that would reduce the fitness of the whole plant is less pronounced.
- a DNA construct can be designed that is capable of specific integration into the target region bringing about targeted mutation in the gene.
- several favorable kind of mutations may be created, such as loss of function, dominant negative, altered substrate specificity, etc.
- 5' and 3' noncoding regions, as well as other regulatory regions may be used. In plants so far the efficiency of this method is low, however it is expected that it can be improved in the future [Offriga et al., Transgenic Res. 1, pp. 114-123 (1992), Vergunst and Hooykaas, Crit. Rev. In Plant Sci. 18, pp. 1-31 (1999)].
- Oligonucleotide chimeras.Targeted mutation can be obtained by introducing short DNA or RNA nucleotides into the cell that are homologous to the target sequence. Efficiency of this method is also low at present [Hohn and Puchta, Proc. Natl. Acad. Sci. USA 96, pp. 8321-8323 (1999)].
- a dominant negative variant of a protein may disturb the function of the target polypeptide by binding to it [Ferrario S. et al., Plant Cell 16, pp. 1490-1505 (2004)], or alternatively, similar effect can be achieved by binding or changing the substrate of the protein [Niki T. et al., Plant Physiol. 126, pp. 965-972 (2001)].
- Recombinant antibodies may also be expressed in plant cells [Conrad and Manteuffel, Trends in Plant Sci. 6, pp. 399-402 (2001)], where the antibody can recognize and inactivate the antigene that may be a protein or other.
- the DNA construct intended to abolish the expression of a target gene may be needed to propagate and select those cells.
- the transgenic cells are selected on appropriate media, then grown into calli by tissue culture methods. Shoot development is induced from the calli on appropriate media, followed by regeneration of the whole plant. Certain parts of the plant (e.g. buds) can be transformed directly by Agrobacterium at a competent developmental stage. In this case, seeds are selected to obtain transgenic progeny.
- Transgene constructs may be linked to selectable markers in order to differentiate between transformed and wild type genotypes. Useful markers are different antibiotics (e.g.
- kanamycin, G418, bleomycin, hygromycin, chloramfenicol, etc.) or some herbicides e.g. BASTA.
- Components of DNA constructs introduced may derive from the same host plant (endogen), or from foreign organism (exogen origin). 'Foreign' means that the DNA sequence is not found in the genome of the host plant. Heterologous constructs contain at least one region of foreign origin.
- transgenic plants can be propagated and harvested, and their seeds may be collected.
- Heritable alterations have been made in their genome that all offspring will carry. In appropriate genetic context, the tissues and organs affected will show the desired phenotype.
- the introduced transgenes and genetic alterations may be transferred into appropriate recipients by conventional crossings.
- random mutagenesis In addition to the targeted transgenic constructs, destruction of a gene can be achieved by random mutagenesis as well. With some of these methods it is easier to introduce mutations, but this advantage is balanced by the more difficult selection procedures to obtain the desired, in our case drought tolerant, mutants. Methods for random mutagenesis are well known to the person skilled in the art. Non-limiting examples include irradiation, chemical mutagenesis, treatment with modified nucleotides, etc. [Negrutiul., In vitro mutagenesis., pp. 19-38., in: Plant Cell Line Selection, Dix, P.J. (ed.), VCH Verlag GmbH. (1990)]. Random mutagenesis can be done by using mutator DNA constructs with known sequence.
- T-DNA mutagenesis where large scale plant transformation is used to generate a mutant population [e.g. Chen et al., Distribution and characterization of over 1000 T-DNA tags in rice genome., Plant J. 36, pp. 105-113 (2003)].
- this population may contain mutants with loss of function, gain of function, or mutants with altered functions [Alonso et al., Genome-wide insertional mutagenesis of Arabidopsis thaliana., Science 301, pp. 653-657 (2003), Sessions et al., Ahigh- throughput Arabidopsis reverse genetics system., Plant Cell 14, pp.
- transposons may be used to obtain mutant populations.
- the transposons may be endogenous or foreign (heterolog) to the species, and can be introduced either by one of the transformation methods outlined above or traditional sexual crossing [May et al., Maize-targeted mutagenesis: A knockout resource for maize., Proc. Natl. Acad. Sci. USA 100, pp.
- Selection of the mutant with improved drought tolerance from the random mutagenized population can be achieved by direct screening for the trait, or in one of the following ways. If we already possess an induced transgenic mutant obtained by any of the ways described above, it may help in the selection procedure. As we mentioned, in addition to the improved drought tolerance, the morphology of the cbp20 mutant is also slightly changed compared to wild type. These visible pleiotropic traits may aid in selecting the mutant from a large mutant population, with more effective screening of the visible phenotype. Pleiotropic effects may vary among species, which can be tested by a transgenic mutant created by silencing.
- the desired mutant may be selected from the mutant population created by random mutagenizer DNA constructs by several way. PCR reactions may be performed based on the sequences of the target gene (including promoter and other regulatory regions) and that of the mutator sequence [for example see: Krysan et al., Identification of transferred DNA insertions within Arabidopsis genes involved in signal transduction and ion transport., Proc. Natl. Acad. Sci. USA 93, pp. 8145-8150 (1996)]. Screening may be accomplished with degenerate primers if the exact sequence of the target gene is unknown, but a characteristic motif is chosen (e.g.
- RNA binding, kinase domain, etc. [Young et al., Efficient screening of Arabidopsis T-DNA insertion lines using degenerate primers., Plant Physiol. 125, pp. 513-518 (2001)].
- sequences flanking the mutator DNA may be amplified by PCR. From among these sequences the gene of interest can be selected. For an overview of the method see Maes et al., Plant tagnology Trends in Plant Sci. 4, pp. 90-96 (1999).
- a further possibility to select a particular mutant from a mutant population is the use of the TILLING method [(McCallum et al., Targeting Induced Local Lesions IN Genomes (TILLING) for plant functional genomics., Plant Physiol. 123, pp. 439-442 (2000)].
- TILLING Targeting Induced Local Lesions IN Genomes
- the targeted gene is specifically amplified from individuals of a random mutagenized population, then a wild type target sequence hybridized. With the help of an enzyme specifically cutting mismatched heteroduplex DNA, individuals carrying point mutations or small sequence changes in the gene of interest can be selected.
- Wild type Arabidopsis (ecotype Columbia) have been randomly mutagenized by Agrobacterium infiltration with a T-DNA construct [pPCV6NFHyg; Koncz, C, Mayerhofer, R., Koncz-Kalman, Z., Nawrath, C, Reiss, B., Redei, G.P. ⁇ s Schell, J., Isolation of a gene encoding a novel chloroplast protein by T-DNA tagging in Arabidopsis thaliana., EMBO J . 9, pp. 1337-1346 (1990)], creating a mutant plant population. Hygromycin resistant transformants were grown, their seeds were harvested. Using phenotypic screening of approx. 10,000 T2 progeny, a plant line has been selected showing more compact stature than wild type, slightly delayed development and serrated leaf margins (Figure 1). The mutant was fertile and in most characteristics very similar to the wild type.
- the plant genomic sequences flanking the T-DNA have been cloned by cutting the genomic DNA with an appropriate restriction enzyme (Hindlll), religating and transforming it into competent Escherichia coli.
- the plasmid construct rescued has been sequenced with T-DNA specific primers. This way in vitro was found out that the T-DNA was inserted into the second exon of gene At5g44200 on chromosome 5, which codes Cap Binding Protein 20.
- the T-DNA substituted a 36 base sequence between base pairs 62147 and 62183 of the MLNl PI clone.
- the integrated large piece of T-DNA disrupts the transcription and translation of the gene at this point. In the mutant only the first exon and part of the second exon can be transcribed. The produced truncated mRNA is degraded, we could not detect it in our Northern experiment ( Figure 4).
- mutant plants were tested under different biotic and abiotic stresses. They showed considerable differences from wild type under water deprivation stress. Mutant and wild type plants were sawn and grown under normal conditions for 8 weeks then they were left without watering. The phenotype of the mutants were markedly different from wild type after approx. 6-8 days of drought (Figure 5); they tolerated water deprivation better. As mutants develop somewhat slower than wild type, in the above experiment we used plants of approx. the same developmental stage, but at slightly different age. By using plants of exactly the same age however, similar results could be achieved.
- Example 2 Example 2
- Random mutagenesis is performed by conventionally used mutagens (e.g. irradiation, chemical mutagenesis). The mutant population screened phenotypically for the visible traits of the cbp20 mutant, whereby a small number of mutants will be selected. This small population is screened extensively for water stress resistance, yielding the transgene-free drought tolerant mutant.
- mutagens e.g. irradiation, chemical mutagenesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP0303778 | 2003-11-19 | ||
HU0303778A HUP0303778A2 (en) | 2003-11-19 | 2003-11-19 | Plant with increased drought resistance |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005048693A2 true WO2005048693A2 (fr) | 2005-06-02 |
WO2005048693A3 WO2005048693A3 (fr) | 2005-10-27 |
Family
ID=89981794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2004/052440 WO2005048693A2 (fr) | 2003-11-19 | 2004-11-16 | Plante a tolerance accrue a la secheresse |
Country Status (2)
Country | Link |
---|---|
HU (1) | HUP0303778A2 (fr) |
WO (1) | WO2005048693A2 (fr) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008053059A1 (fr) * | 2006-10-31 | 2008-05-08 | Calantia Biotech, S.L. | Utilisation de la mutation d'ocp3 comme régulateur de la résistance à la sécheresse des plantes |
WO2010046422A2 (fr) | 2008-10-22 | 2010-04-29 | Basf Se | Utilisation d'herbicides de type auxine sur des plantes cultivées |
WO2010046423A2 (fr) | 2008-10-22 | 2010-04-29 | Basf Se | Utilisation d'herbicides sulfonylurées sur des plantes cultivées |
WO2014053395A1 (fr) | 2012-10-01 | 2014-04-10 | Basf Se | Utilisation de composés de n-thio-anthranilamide sur des plantes cultivées |
WO2014079820A1 (fr) | 2012-11-22 | 2014-05-30 | Basf Se | Utilisation de composés d'anthranilamides pour réduire les infections virales véhiculées par les insectes |
EP3028573A1 (fr) | 2014-12-05 | 2016-06-08 | Basf Se | Utilisation d'un triazole fongicide sur des plantes transgéniques |
WO2016091674A1 (fr) | 2014-12-12 | 2016-06-16 | Basf Se | Utilisation de cyclaniliprole sur des plantes cultivées |
WO2016162371A1 (fr) | 2015-04-07 | 2016-10-13 | Basf Agrochemical Products B.V. | Utilisation d'un composé de carboxamide insecticide contre les nuisibles sur des plantes cultivées |
EP3338552A1 (fr) | 2016-12-21 | 2018-06-27 | Basf Se | Utilisation d'un fongicide tetrazolinone sur des plantes transgéniques |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1033405A2 (fr) * | 1999-02-25 | 2000-09-06 | Ceres Incorporated | Fragments d'ADN avec des séquences déterminées et polypeptides encodées par lesdits fragments |
WO2001096585A2 (fr) * | 2000-06-14 | 2001-12-20 | The Regents Of The University Of California | Modulation de la transduction du signal de l'acide abscisique dans des plantes |
WO2002081696A2 (fr) * | 2001-04-06 | 2002-10-17 | Syngenta Participations Ag | Proteine 80 se liant a une coiffe nucleaire oryza sativa |
-
2003
- 2003-11-19 HU HU0303778A patent/HUP0303778A2/hu unknown
-
2004
- 2004-11-16 WO PCT/IB2004/052440 patent/WO2005048693A2/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1033405A2 (fr) * | 1999-02-25 | 2000-09-06 | Ceres Incorporated | Fragments d'ADN avec des séquences déterminées et polypeptides encodées par lesdits fragments |
WO2001096585A2 (fr) * | 2000-06-14 | 2001-12-20 | The Regents Of The University Of California | Modulation de la transduction du signal de l'acide abscisique dans des plantes |
WO2002081696A2 (fr) * | 2001-04-06 | 2002-10-17 | Syngenta Participations Ag | Proteine 80 se liant a une coiffe nucleaire oryza sativa |
Non-Patent Citations (3)
Title |
---|
DATABASE EMBL [Online] 18 July 1997 (1997-07-18), "Arabidopsis thaliana genomic DNA, chromosome 5, P1 clone:MLN1." XP002328902 retrieved from EBI accession no. EM_PRO:AB005239 Database accession no. AB005239 * |
HUGOUVIEUX VERONIQUE ET AL: "Localization, ion channel regulation, and genetic interactions during abscisic acid signaling of the nuclear mRNA cap-binding protein, ABH1." PLANT PHYSIOLOGY (ROCKVILLE), vol. 130, no. 3, November 2002 (2002-11), pages 1276-1287, XP002328697 ISSN: 0032-0889 * |
KMIECIAK M ET AL: "Cloning and characterization of two subunits of Arabidopsis thaliana nuclear cap-binding complex" GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 283, no. 1-2, 23 January 2002 (2002-01-23), pages 171-183, XP004339904 ISSN: 0378-1119 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008053059A1 (fr) * | 2006-10-31 | 2008-05-08 | Calantia Biotech, S.L. | Utilisation de la mutation d'ocp3 comme régulateur de la résistance à la sécheresse des plantes |
ES2304304A1 (es) * | 2006-10-31 | 2008-10-01 | Universidad Politecnica De Valencia | Uso dea mutacionen ocp3 como regulador de la resistencia a sequia en plantas. |
WO2010046422A2 (fr) | 2008-10-22 | 2010-04-29 | Basf Se | Utilisation d'herbicides de type auxine sur des plantes cultivées |
WO2010046423A2 (fr) | 2008-10-22 | 2010-04-29 | Basf Se | Utilisation d'herbicides sulfonylurées sur des plantes cultivées |
WO2014053395A1 (fr) | 2012-10-01 | 2014-04-10 | Basf Se | Utilisation de composés de n-thio-anthranilamide sur des plantes cultivées |
WO2014079820A1 (fr) | 2012-11-22 | 2014-05-30 | Basf Se | Utilisation de composés d'anthranilamides pour réduire les infections virales véhiculées par les insectes |
EP3028573A1 (fr) | 2014-12-05 | 2016-06-08 | Basf Se | Utilisation d'un triazole fongicide sur des plantes transgéniques |
WO2016091674A1 (fr) | 2014-12-12 | 2016-06-16 | Basf Se | Utilisation de cyclaniliprole sur des plantes cultivées |
WO2016162371A1 (fr) | 2015-04-07 | 2016-10-13 | Basf Agrochemical Products B.V. | Utilisation d'un composé de carboxamide insecticide contre les nuisibles sur des plantes cultivées |
EP3338552A1 (fr) | 2016-12-21 | 2018-06-27 | Basf Se | Utilisation d'un fongicide tetrazolinone sur des plantes transgéniques |
Also Published As
Publication number | Publication date |
---|---|
WO2005048693A3 (fr) | 2005-10-27 |
HU0303778D0 (en) | 2004-03-01 |
HUP0303778A2 (en) | 2007-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1003868B1 (fr) | BLé RHAT GENE POUR REGULATION GENETIQUE DE LA CROISSANCE ET DU DEVELOPPEMENT VEGETAUX | |
WO1999055840A1 (fr) | Facteur de transcription et technique permettant de reguler la croissance, la qualite et la tolerance au stress des semences | |
JP2004527201A (ja) | アルフィン1の発現、ならびに根の生長および根の特定の遺伝子活性化の増大したトランスジェニック植物を生産する方法 | |
US20090288226A1 (en) | Method for manipulating growth, yield, and architecture in plants | |
WO2001038551A1 (fr) | Regulation de l'expression d'un gene du groupe polycomb destinee a augmenter la taille des graines chez les plantes | |
US7638681B2 (en) | Auxin transport proteins | |
WO2005048693A2 (fr) | Plante a tolerance accrue a la secheresse | |
WO2004106531A1 (fr) | Procede de manipulation de croissance, de rendement et d'architecture de plantes | |
CA2422620C (fr) | Methode de controle du caractere de monocotyledons par modification et/ou surexpression du gene de la monooxygenase-cytochrome p-450 participant a la biosynthese de brassinosteroides et monocotyledons ainsi modifies | |
Quaedvlieg et al. | Identification of a light-regulated MYB gene from an Arabidopsis transcription factor gene collection | |
Grevelding et al. | Characterisation of a new allele of pale cress and its role in greening in Arabidopsis thaliana | |
AU3574699A (en) | Method of dwarfing plants | |
US7265264B2 (en) | Gene for a Dof transcription factor capable of altering the size and stature of a plant | |
US7560612B2 (en) | Early-inflorescence-preferred regulatory elements and uses thereof | |
US20030014776A1 (en) | Maternal effect gametophyte regulatory polynucleotide | |
US20080216200A1 (en) | Alternative splicing factors polynucleotides, polypeptides and uses thereof | |
WO2009133025A1 (fr) | Système de surexpression contrôlée d'adnc dans arabidopsis | |
KR101112673B1 (ko) | 식물의 뿌리털 발달 조절 유전자 rhs10 및 이를 이용한 식물의 뿌리털 발달 조절 방법 | |
AU2001253682B2 (en) | Mre11 orthologue and uses thereof | |
US8410337B2 (en) | Plant tubby-like proteins | |
US7314756B2 (en) | Plant tubby-like proteins | |
US6887988B2 (en) | Plant reproduction polynucleotides and methods of use | |
AU2002252825B2 (en) | Modification of plant and seed development and plant responses to stresses and stimuli | |
US7164006B1 (en) | Alteration of plant meristem function by manipulation of the Retinoblastoma-like plant RRB gene | |
AU2012200697B2 (en) | Modification of plant and seed development and plant responses to stresses and stimuli (4) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |